Die with a smile: antidepressants against COVID-19
“Fluvoxamine could certainly be something you wanna put in the tool chest. ‘Cause it looks as if it has the promise to reduce the likelihood of severe illness.” – Francis Collins, NIH Director.
By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
“Fluvoxamine could certainly be something you wanna put in the tool chest. ‘Cause it looks as if it has the promise to reduce the likelihood of severe illness.” – Francis Collins, NIH Director.
Male boldness causes COVID-19 death, go figure. This ridiculous quackery from Brazil is based on fudged clinical trials, sponsored by an obscure Californian hair loss business, and even Torello Lotti is on board!
En-Bing Lin “has published more than 80 peer-reviewed articles, received over $535,000 in grant funding and given 74 external presentations, including 14 keynote speeches at international mathematic conferences.”
Disappointed of Carey Gillam’s book about Lawyers’ Adventures, I blog about the Monsanto and glyphosate affair.
Autistic Neanderthal minibrains operating crab robots via brain waves of newborn babies are to be launched into outer space for the purpose of interstellar colonization. No, I am not insane. Science Has Spoken.
“Patients affected with ALS now need to know that we are working for them […] We feel completely motivated and convinced to dedicate our careers to fight ALS.” Claudio Hetz, Photoshop artist.
“We all hype our work. We want to tell people our work is important. These patients, many of them coming to enroll in these trials, they have no other hope.” -Steven Houser, Hero of Research Ethics, Temple University
Ivermectin is the new hydroxychloroquine. But who is its new Raoult? What if the cast of the 2021 sequel will remain otherwise the same?
David Sabatini, remember that story? Well, it seems the conclusions were not affected. I take an ill-informed look at the mTOR signalling research field, to understand how photoshopped data gets to be independently verified by other labs.
Ashutosh Tiwari’s scamference activities continue. Now the University of Magdeburg in Germany is very excited about a medal from the International Association of Advanced Materials.









